These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14020499)

  • 41. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.
    Gomora JC; Daud AN; Weiergräber M; Perez-Reyes E
    Mol Pharmacol; 2001 Nov; 60(5):1121-32. PubMed ID: 11641441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Megaloblastic anaemia during combined phensuximide and phenobarbitone therapy.
    DOIG A; STANTON JB
    Br Med J; 1961 Oct; 2(5258):998-9. PubMed ID: 13886968
    [No Abstract]   [Full Text] [Related]  

  • 43. Conventional anticonvulsant drugs in the guinea pig kindling model of partial seizures: effects of acute phenobarbital, valproate, and ethosuximide.
    Gilbert TH; Corley SM; Teskey GC
    Exp Brain Res; 2002 Oct; 146(3):336-44. PubMed ID: 12232690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ethosuximide and tetramethylsuccinimide on cultured cortical neurons.
    Barnes DM; Dichter MA
    Neurology; 1984 May; 34(5):620-5. PubMed ID: 6324033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy.
    Strong JM; Abe T; Gibbs EL; Atkinson AJ
    Neurology; 1974 Mar; 24(3):250-5. PubMed ID: 4855951
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthesis and anticonvulsant properties of N-methylpyridyl derivatives of m- and p-bromophenylsuccinimides.
    Zejc A; Obniska J; Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1987; 39(1):91-5. PubMed ID: 3671189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkylation reactions of hydantoins and succinimides.
    Yung DK; Forrest TP; Gilroy ML; Vohra MM
    J Pharm Sci; 1973 Nov; 62(11):1764-8. PubMed ID: 4148450
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticonvulsant drugs: mechanisms of action.
    Macdonald RL; McLean MJ
    Adv Neurol; 1986; 44():713-36. PubMed ID: 2871724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.
    Barton ME; Eberle EL; Shannon HE
    Eur J Pharmacol; 2005 Oct; 521(1-3):79-85. PubMed ID: 16171802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACID-BASE, ELECTROLYTE, AND AMINO-ACID METABOLISM IN CHILDREN WITH PETIT MAL. ETIOLOGIC SIGNIFICANCE AND MODIFICATION BY ANTICONVULSANT DRUGS AND THE KETOGENIC DIET.
    MILLICHAP JG; JONES JD
    Epilepsia; 1964 Sep; 5():239-55. PubMed ID: 14232248
    [No Abstract]   [Full Text] [Related]  

  • 51. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.
    Singsen BH; Fishman L; Hanson V
    Pediatrics; 1976 Apr; 57(4):529-34. PubMed ID: 1083501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved isocratic liquid-chromatographic simultaneous measurement of phenytoin, phenobarbital, primidone, carbamazepine, ethosuximide, and N-desmethylmethsuximide in serum.
    Szabo GK; Browne TR
    Clin Chem; 1982 Jan; 28(1):100-4. PubMed ID: 6895720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of bovine brain aldehyde reductase by anticonvulsant compounds in vitro.
    Erwin VG; Deitrich RA
    Biochem Pharmacol; 1973 Oct; 22(20):2615-24. PubMed ID: 4148709
    [No Abstract]   [Full Text] [Related]  

  • 54. The anticonvulsant ethosuximide disrupts sensory function to extend C. elegans lifespan.
    Collins JJ; Evason K; Pickett CL; Schneider DL; Kornfeld K
    PLoS Genet; 2008 Oct; 4(10):e1000230. PubMed ID: 18949032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discriminative stimulus properties of ethosuximide in the pigeon.
    Clark RD; Schlinger H; Poling A
    Psychopharmacology (Berl); 1987; 93(4):466-9. PubMed ID: 3124180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients.
    Giaccone M; Bartoli A; Gatti G; Marchiselli R; Pisani F; Latella MA; Perucca E
    Br J Clin Pharmacol; 1996 Jun; 41(6):575-9. PubMed ID: 8799524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [1H-NMR-Spectroscopic study of various anticonvulsants. 4. NMR-spectroscopy of drugs].
    Nuhn P; Zschunke A; Woitkowitz P
    Pharmazie; 1973 Jul; 28(7):484-5. PubMed ID: 4767505
    [No Abstract]   [Full Text] [Related]  

  • 58. Anticonvulsant interaction of cannabidiol and ethosuximide in rats.
    Consroe PF; Wolkin AL
    J Pharm Pharmacol; 1977 Aug; 29(8):500-1. PubMed ID: 19602
    [No Abstract]   [Full Text] [Related]  

  • 59. Methsuximide for intractable childhood seizures.
    Tennison MB; Greenwood RS; Miles MV
    Pediatrics; 1991 Feb; 87(2):186-9. PubMed ID: 1987529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MECHANISM OF ANTICONVULSANT ACTION OF KETOGENIC DIET. STUDIES IN ANIMALS WITH EXPERIMENTAL SEIZURES AND IN CHILDREN WITH PETIT MAL EPILEPSY.
    MILLICHAP JG; JONES JD; RUDIS BP
    Am J Dis Child; 1964 Jun; 107():593-604. PubMed ID: 14133819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.